[Intracellular signal transduction of vascular injury in insulin resistance].
Yoshizumi
Masanori
M
yoshizu@naramed-u.ac.jp
Ishizawa
Keisuke
K
Izawa
Yuki
Y
Tamaki
Toshiaki
T
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000628:therapy; D004195:Disease Models, Animal; D015195:Drug Design; D005081:Exercise Therapy; D006801:Humans; D007333:Insulin Resistance; D019808:Losartan / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000188:drug therapy / Q000209:etiology*; D048052:Mitogen-Activated Protein Kinase 3 / Q000502:physiology; D051381:Rats; D020334:Rats, Inbred OLETF; D015398:Signal Transduction / Q000502:physiology*; D019061:src-Family Kinases / Q000502:physiology
D047228:Angiotensin II Type 1 Receptor Blockers; D019061:src-Family Kinases; D048052:Mitogen-Activated Protein Kinase 3; D019808:Losartan